Figure 2.

The columns show the distribution of the different global H4K20 methylation levels in non-malignant prostate tissue (n = 23), localized prostate cancer (PCA; n = 113), metastatic hormone-naïve prostate cancer (mPCA; n = 30) and castration-resistant prostate cancer (CRPC; n = 34). H4K20 methylation levels were categorized into weak (≤ 4), moderate (5-8) and strong (≥ 9).

Behbahani et al. BMC Urology 2012 12:5   doi:10.1186/1471-2490-12-5
Download authors' original image